Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2697 |
|
Actual shortage: | 238 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2450 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
23 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-PAROXETINE | 10MG | TABLET | Resolved | 2017-03-13 | 2017-10-10 | 1167 |
TEVA-PAROXETINE | 20MG | TABLET | Resolved | 2017-03-13 | 2017-10-10 | 1175 |
TEVA-PAROXETINE | 20MG | TABLET | Resolved | 2017-03-13 | 2017-10-10 | 1179 |
TEVA-PAROXETINE | 20MG | TABLET | Resolved | 2017-03-13 | 2017-10-10 | 1191 |
TEVA-PAROXETINE | 30MG | TABLET | Resolved | 2017-03-13 | 2017-10-10 | 1199 |
TEVA-PAROXETINE | 30MG | TABLET | Resolved | 2017-03-13 | 2017-10-10 | 1204 |
TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Resolved | 2017-03-13 | 2018-05-11 | 1226 |
TEVA-PAROXETINE | 30MG | TABLET | Resolved | 2017-03-13 | 2017-10-10 | 1454 |
TEVA-RANITIDINE | 150MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1510 |
TEVA-RANITIDINE | 300MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1522 |
TEVA-RANITIDINE | 300MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1534 |
TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Resolved | 2017-03-13 | 2017-10-10 | 1552 |
TEVA-SPIRONOLACTONE | 100MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1560 |
TEVA-RISPERIDONE | 0.5MG | TABLET | Resolved | 2017-03-13 | 2023-10-03 | 1566 |
TEVA-SPIRONOLACTONE | 25MG | TABLET | Resolved | 2017-03-13 | 2017-10-11 | 1568 |
TEVA-TRIMEL | 400MG 80MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1582 |
TEVA-TRIMEL | 40MG 8MG | SUSPENSION | Actual shortage | 2017-03-13 | 2017-10-13 | 1591 |
TEVA-RISEDRONATE | 150MG | TABLET | Resolved | 2017-03-13 | 2017-10-10 | 1607 |
TEVA-TRIMEL | 40MG 8MG | SUSPENSION | Actual shortage | 2017-03-13 | 2017-10-13 | 1609 |
TEVA-TERAZOSIN | 10MG | TABLET | Actual shortage | 2017-03-13 | 2020-02-13 | 1619 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ACT NABILONE | 1MG | CAPSULE | Discontinued | 2019-10-31 | 2019-11-01 | 97581 |
TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-31 | 2019-11-01 | 97589 |
TEVA-PAROXETINE | 30MG | TABLET | Discontinued | 2019-12-09 | 2019-12-09 | 100540 |
TEVA-PAROXETINE | 20MG | TABLET | Discontinued | 2019-12-09 | 2019-12-09 | 100547 |
TEVA-ATENOLOL/CHLORTHALIDONE | 25MG 100MG | TABLET | Discontinued | 2020-01-21 | 2020-01-21 | 103781 |
TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION | 0.004% | SOLUTION | Discontinued | 2020-01-21 | 2020-01-21 | 103788 |
TEVA-DEFERASIROX | 125MG | TABLET FOR SUSPENSION | Discontinued | 2020-01-21 | 2020-01-21 | 103791 |
TEVA-DEFERASIROX | 250MG | TABLET FOR SUSPENSION | Discontinued | 2020-01-21 | 2020-01-21 | 103796 |
TEVA-LISINOPRIL (TYPE P) | 20MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104257 |
TEVA-LAMIVUDINE/ZIDOVUDINE | 300MG 150MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104260 |
TEVA-ARIPIPRAZOLE | 5MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104263 |
ACT OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-01-24 | 2020-01-24 | 104277 |
TEVA-ARIPIPRAZOLE | 5MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104283 |
NOVAMOXIN | 250MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104289 |
TEVA-QUININE | 300MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104294 |
TEVA-LEVETIRACETAM | 500MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104304 |
TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
TEVA-TRIMEL | 400MG 80MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106133 |
TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106136 | ||
TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106139 |